Clinical Significance of Low-Triiodothyronine Syndrome in Patients Requiring Non-Surgical Intensive Care ― Triiodothyronine Is a Comprehensive Prognostic Marker for Critical Patients With Cardiovascular Disease ―

DOI Web Site 30 References Open Access
  • Shigihara Shota
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Shirakabe Akihiro
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Kobayashi Nobuaki
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Okazaki Hirotake
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Matsushita Masato
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Shibata Yusaku
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Nishigoori Suguru
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Sawatani Tomofumi
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Okajima Fumitaka
    Department of Endocrinology, Nippon Medical School Chiba Hokusoh Hospital
  • Asai Kuniya
    Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital
  • Shimizu Wataru
    Department of Cardiovascular Medicine, Nippon Medical School

Search this article

Abstract

<p>Background:Low-triiodothyronine (T3) syndrome is a known complication in intensive care unit (ICU) patients, but the underlying mechanisms and prognostic impact are unclear.</p><p>Methods and Results:This study retrospectively enrolled 2,976 patients who required care in the ICU. Of these patients, 2,425 were euthyroid and were divided into normal (n=1,666; free T3[FT3] ≥1.88 µIU/L) and low-FT3(n=759; FT3<1.88 µIU/L) groups. Multivariate logistic regression analysis revealed that prognostic nutritional index >46.03 (odds ratio [OR] 2.392; 95% confidence interval [CI] 1.904–3.005), age (per 1-year increase; OR 1.022; 95% CI 1.013–1.031), creatinine (per 0.1-mg/dL increase; OR 1.019; 95% CI 1.014–1.024), and C-reactive protein (per 1-mg/dL increase; OR 1.123; 95% CI 1.095–1.151) were independently associated with low FT3. Survival rates (within 365 days) were significantly lower in the low-FT3group. A multivariate Cox regression model showed that low FT3was an independent predictor of 365-day mortality (hazard ratio 1.785; 95% CI 1.387–2.297). Low-T3syndrome was significantly more frequent in patients with non-cardiovascular than cardiovascular diseases (73.5% vs. 25.8%). Prognosis was significantly poorer in the low-FT3than normal group for patients with cardiovascular disease, particularly those with acute coronary syndrome and acute heart failure.</p><p>Conclusions:Low-T3syndrome was associated with aging, inflammatory reaction, malnutrition, and renal insufficiency and could lead to adverse outcomes in patients admitted to a non-surgical ICU.</p>

Journal

  • Circulation Reports

    Circulation Reports advpub (0), 578-588, 2021-09-30

    The Japanese Circulation Society

References(30)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top